Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,058 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level.
Patil P, Hillebrecht S, Chteinberg E, López C, Toprak UH, Seufert J, Bernhart SH, Kretzmer H, Bergmann AK, Bens S, Högel J, Müller A, Jebaraj BM, Schrader A, Johansson P, Costa D, Schlesner M, Dürig J, Herling M, Campo E, Stilgenbauer S, Wiehle L, Siebert R. Patil P, et al. Among authors: muller a. Genes Chromosomes Cancer. 2022 Jul;61(7):432-436. doi: 10.1002/gcc.23034. Epub 2022 Mar 29. Genes Chromosomes Cancer. 2022. PMID: 35218115
Exploration of whole genome and transcriptome sequencing data lacks evidence for oncogenic viral elements to drive the pathogenesis of T-cell prolymphocytic leukemia.
Patil P, Toprak UH, Seufert J, Braun T, Bernhart SH, Wiehle L, Müller A, Schlesner M, Herling M, Lichter P, Stilgenbauer S, Siebert R, Zapatka M. Patil P, et al. Among authors: muller a. Leuk Lymphoma. 2022 Dec;63(13):3253-3256. doi: 10.1080/10428194.2022.2116933. Epub 2022 Sep 9. Leuk Lymphoma. 2022. PMID: 36083597 No abstract available.
Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia.
Jebaraj BMC, Müller A, Dheenadayalan RP, Endres S, Roessner PM, Seyfried F, Walliser C, Wist M, Qi J, Tausch E, Mertens D, Fox JA, Debatin KM, Meyer LH, Taverna P, Seiffert M, Gierschik P, Stilgenbauer S. Jebaraj BMC, et al. Among authors: muller a. Blood. 2022 Feb 10;139(6):859-875. doi: 10.1182/blood.2021011516. Blood. 2022. PMID: 34662393 Free article.
Secondary resistance to idelalisib is characterized by upregulation of IGF1R rather than by MAPK/ERK pathway mutations.
Tausch E, Ljungström V, Agathangelidis A, Zapatka M, Scarfò L, Jebaraj BMC, Yosifov DY, Müller A, Munugalavadla V, Degenhardt JD, Ghia P, Rosenquist R, Stilgenbauer S. Tausch E, et al. Among authors: muller a. Blood. 2022 Jun 2;139(22):3340-3344. doi: 10.1182/blood.2021014550. Blood. 2022. PMID: 35377939 Free article. No abstract available.
Acquired BTK mutations associated with resistance to noncovalent BTK inhibitors.
Qi J, Endres S, Yosifov DY, Tausch E, Dheenadayalan RP, Gao X, Müller A, Schneider C, Mertens D, Gierschik P, Wist M, Jebaraj BMC, Stilgenbauer S. Qi J, et al. Among authors: muller a. Blood Adv. 2023 Oct 10;7(19):5698-5702. doi: 10.1182/bloodadvances.2022008955. Blood Adv. 2023. PMID: 36661329 Free PMC article. No abstract available.
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study.
Menne J, Nitschke M, Stingele R, Abu-Tair M, Beneke J, Bramstedt J, Bremer JP, Brunkhorst R, Busch V, Dengler R, Deuschl G, Fellermann K, Fickenscher H, Gerigk C, Goettsche A, Greeve J, Hafer C, Hagenmüller F, Haller H, Herget-Rosenthal S, Hertenstein B, Hofmann C, Lang M, Kielstein JT, Klostermeier UC, Knobloch J, Kuehbacher M, Kunzendorf U, Lehnert H, Manns MP, Menne TF, Meyer TN, Michael C, Münte T, Neumann-Grutzeck C, Nuernberger J, Pavenstaedt H, Ramazan L, Renders L, Repenthin J, Ries W, Rohr A, Rump LC, Samuelsson O, Sayk F, Schmidt BM, Schnatter S, Schöcklmann H, Schreiber S, von Seydewitz CU, Steinhoff J, Stracke S, Suerbaum S, van de Loo A, Vischedyk M, Weissenborn K, Wellhöner P, Wiesner M, Zeissig S, Büning J, Schiffer M, Kuehbacher T; EHEC-HUS consortium. Menne J, et al. BMJ. 2012 Jul 19;345:e4565. doi: 10.1136/bmj.e4565. BMJ. 2012. PMID: 22815429 Free PMC article.
Heart rate variability and stroke or systemic embolism in patients with atrial fibrillation.
Hämmerle P, Aeschbacher S, Schlageter V, Coslovsky M, Hennings E, Krisai P, Coduri F, Blum MR, Rodondi N, Reichlin T, Müller A, Stauber A, Moschovitis G, Rigamonti E, Beer J, Ammann P, Bonati LH, Conen D, Osswald S, Kühne M, Zuern CS; Swiss-AF Investigators. Hämmerle P, et al. Among authors: muller a. Heart Rhythm. 2024 May 16:S1547-5271(24)02570-0. doi: 10.1016/j.hrthm.2024.05.028. Online ahead of print. Heart Rhythm. 2024. PMID: 38762133 Free article.
Isomer-specific photofragmentation of C3H3+ at the carbon K-edge.
Reinwardt S, Cieslik P, Buhr T, Perry-Sassmannshausen A, Schippers S, Müller A, Trinter F, Martins M. Reinwardt S, et al. Among authors: muller a. Phys Chem Chem Phys. 2024 May 16. doi: 10.1039/d4cp00370e. Online ahead of print. Phys Chem Chem Phys. 2024. PMID: 38752716
Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel.
Aytekin A, Scalamogna M, Coughlan JJ, Lahu S, Ndrepepa G, Menichelli M, Mayer K, Wöhrle J, Bernlochner I, Witzenbichler B, Hochholzer W, Sibbing D, Angiolillo DJ, Hemetsberger R, Tölg R, Valina C, Müller A, Kufner S, Liebetrau C, Xhepa E, Hapfelmeier A, Sager HB, Joner M, Richardt G, Laugwitz KL, Neumann FJ, Schunkert H, Schüpke S, Kastrati A, Cassese S. Aytekin A, et al. Among authors: muller a. Clin Res Cardiol. 2024 May 13. doi: 10.1007/s00392-024-02454-x. Online ahead of print. Clin Res Cardiol. 2024. PMID: 38740722
6,058 results